60662-33-1

• 常用中文名：结晶紫九水合物
• 常用英文名：Crystal Violet Nonahydrate [Ion association reagent for spectrophotometric analysis]
• CAS号：60662-33-1
• 分子式：C₂₅H₃₀ClN₃
• 分子量：407.97900
• 相关类别： 染料及颜料 染料 碱性染料
• 发布时间：2018-09-17 20:40:11
• 更新时间：2024-01-18 21:10:53
• 分光光度分析法用离子缔合试剂

名称

• 中文名: 结晶紫九水合物
• 英文名: Crystal Violet Nonahydrate
• 中文别名: 结晶紫; 碱性紫 3
• 英文别名: 4-{Bis[4-(dimethylamino)phenyl]methylene}-N,N-dimethyl-2,5-cycloh exadien-1-iminium chloride

物化性质

• 熔点: 211°C(dec.)(lit.)
• 分子式: C₂₅H₃₀ClN₃
• 分子量: 407.97900
• 精确质量: 407.21300
• PSA: 9.49000
• LogP: 1.46360
• 储存条件: 室温

MSDS

Section I.Chemical Product and Company Identification Chemical NameCrystal Violet [Ion association reagent for spectrophotometric analysis.] Portland OR Basic Violet 3 Synonym Chemical FormulaC25H30ClN3•9H2O CAS Number548-62-9 Section II.Composition and Information on Ingredients Chemical NameCAS Number Percent (%)TLV/PELToxicology Data Crystal Violet548-62-9----------This chemical is classified as aRat LD50 (oral) 420mg/kg [Ion association reagent for spectrophotometric analysis.] carcinogen. There is noMouse LD50 (oral) 96mg/kg acceptable exposure limit for aRabbit LD50 (intraperitoneal) carcinogen.5mg/kg Section III. Hazards Identification Acute Health EffectsToxic if ingested or inhaled. Avoid prolonged contact with this material. Overexposure may result in serious illness or death. Irritating to eyes and skin on contact. Inhalation causes irritation of the lungs and respiratory system. Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is characterized by itching, scaling, reddening, or, occasionally, blistering. Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound. CARCINOGENIC EFFECTS : Chronic Health Effects Rat-TDLo - ROUTE: Oral; DOSE: 10950 mg/kg/2Y continuous TOXIC EFFECTS: Tumorigenic - Carcinogenic by RTECS criteria Endocrine - Thyroid tumors Mouse-TDLo - ROUTE: Oral; DOSE: 25750 mg/kg/2Ycontinuous TOXIC EFFECTS: Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, and Bladder - Tumors Tumorigenic Effects - Ovarian tumors MUTAGENIC EFFECTS : Not available. TERATOGENIC EFFECTS : DEVELOPMENTAL TOXICITY: Rat-TDLo - ROUTE: Oral; DOSE: 100 mg/kg; DURATION: female 6-15D of pregnancy TOXIC EFFECTS: Specific Developmental Abnormalities -Musculoskeletal system Specific Developmental Abnormalities -Urogenital system Rat-TDLo - ROUTE: Oral; DOSE: 100 mg/kg; DURATION: female 6-15D of pregnancy TOXIC EFFECTS: Effects on Embryo or Fetus - Fetotoxicity (except death, e.g., stunted fetus) Effects on Embryo or Fetus - Fetal death Specific Developmental Abnormalities - Musculoskeletal system Repeated exposure to an highly toxic material may produce general deterioration of health by an accumulation in one or many human organs. Section IV.First Aid Measures Eye ContactCheck for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical attention. Skin ContactIn case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical attention immediately. InhalationIf the victim is not breathing, perform mouth-to-mouth resuscitation. Loosen tight clothing such as a collar, tie, belt or waistband. If breathing is difficult, oxygen can be administered. Seek medical attention if respiration problems do not improve. Continued on Next Page Crystal Violet [Ion association reagent for spectrophotometric analysis.] IngestionINDUCE VOMITING by sticking finger in throat. Lower the head so that the vomit will not reenter the mouth and throat. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not breathing, perform mouth-to-mouth resuscitation. Examine the lips and mouth to ascertain whether the tissues are damaged, a possible indication that the toxic material was ingested; the absence of such signs, however, is not conclusive. Section V.Fire and Explosion Data Not available. May be combustible at high temperature.Auto-Ignition Flammability Flammable LimitsNot available. Flash PointsNot available. Combustion ProductsThese products are toxic carbon oxides (CO, CO2), nitrogen oxides (NO, NO2), halogenated compounds. WARNING: Highly toxic HCl gas is produced during combustion. Fire HazardsNot available. Risks of explosion of the product in presence of mechanical impact: Not available. Explosion Hazards Risks of explosion of the product in presence of static discharge: Not available. Fire Fighting MediaSMALL FIRE: Use DRY chemical powder. and InstructionsLARGE FIRE: Use water spray, fog or foam. DO NOT use water jet. Consult with local fire authorities before attempting large scale fire-fighting operations. Section VI.Accidental Release Measures Spill CleanupEnvironmentally hazardous material. Toxic material. Irritating material. Carcinogenic material. Light-sensitive material. Stop leak if without risk. DO NOT get water inside container. DO NOT touch spilled material. Use water spray to reduce Instructions vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Eliminate all sources of ignition. Consult federal, state, and/or local authorities for assistance on disposal. Section VII. Handling and Storage ENVIRONMENTAL HAZARD. TOXIC. IRRITANT. CARCINOGEN. LIGHT-SENSITIVE. Keep locked up. Keep away from Handling and Storage heat. Mechanical exhaust required. When not in use, tightly seal the container and store in a dry, cool place. Avoid Information excessive heat and light. DO NOT ingest. Do not breathe dust. Wear suitable protective clothing. If ingested, seek medical advice immediately and show the container or the label. Treat symptomatically and supportively. Always store away from incompatible compounds such as oxidizing agents. Section VIII. Exposure Controls/Personal Protection Engineering ControlsUse process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants below the exposure limit. Personal ProtectionSplash goggles. Lab coat. Dust respirator. Gloves. A MSHA/NIOSH approved respirator must be used to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this product. This chemical is classified as a carcinogen. There is no acceptable exposure limit for a carcinogen. Exposure Limits Section IX. Physical and Chemical Properties Physical state @ 20°CGreen crystal.SolubilityNot available. Not available. Specific Gravity Molecular Weight407.98 (Anh)Partition CoefficientNot available. Boiling PointNot available.Not available. Vapor Pressure Melting PointNot available.Vapor DensityNot available. Not available.Not available. Refractive IndexVolatility Critical TemperatureNot available.OdorNot available. Not available.Not available. ViscosityTaste Section X.Stability and Reactivity Data This material is stable if stored under proper conditions. (See Section VII for instructions) Stability Conditions of InstabilityAvoid excessive heat and light. IncompatibilitiesReactive with strong oxidizing agents, strong reducing agents. Continued on Next Page Crystal Violet [Ion association reagent for spectrophotometric analysis.] Section XI.Toxicological Information BO9000000 RTECS Number Eye contact. Ingestion. Inhalation. Skin contact. Routes of Exposure Toxicity DataRat LD50 (oral) 420mg/kg Mouse LD50 (oral) 96mg/kg Rabbit LD50 (intraperitoneal) 5mg/kg Chronic Toxic EffectsCARCINOGENIC EFFECTS : Rat-TDLo - ROUTE: Oral; DOSE: 10950 mg/kg/2Y continuous TOXIC EFFECTS: Tumorigenic - Carcinogenic by RTECS criteria Endocrine - Thyroid tumors Mouse-TDLo - ROUTE: Oral; DOSE: 25750 mg/kg/2Ycontinuous TOXIC EFFECTS: Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, and Bladder - Tumors Tumorigenic Effects - Ovarian tumors MUTAGENIC EFFECTS : Not available. TERATOGENIC EFFECTS : DEVELOPMENTAL TOXICITY: Rat-TDLo - ROUTE: Oral; DOSE: 100 mg/kg; DURATION: female 6-15D of pregnancy TOXIC EFFECTS: Specific Developmental Abnormalities -Musculoskeletal system Specific Developmental Abnormalities -Urogenital system Rat-TDLo - ROUTE: Oral; DOSE: 100 mg/kg; DURATION: female 6-15D of pregnancy TOXIC EFFECTS: Effects on Embryo or Fetus - Fetotoxicity (except death, e.g., stunted fetus) Effects on Embryo or Fetus - Fetal death Specific Developmental Abnormalities - Musculoskeletal system Repeated exposure to an highly toxic material may produce general deterioration of health by an accumulation in one or many human organs. Acute Toxic EffectsToxic if ingested or inhaled. Avoid prolonged contact with this material. Overexposure may result in serious illness or death. Irritating to eyes and skin on contact. Inhalation causes irritation of the lungs and respiratory system. Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is characterized by itching, scaling, reddening, or, occasionally, blistering. Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound. Section XII.Ecological Information EcotoxicityNot available. Hexamethyl-p-rosaniline chloride's production and uses as a dye and topical antibacterial medication, both human and Environmental Fate veterinary, may result in its release to the environment through various waste streams. If released to air, an estimated vapor pressure of 1.9X10-14 mm Hg at 25 deg C indicates hexamethyl-p-rosaniline chloride will exist solely in the particulate phase in the ambient atmosphere. Particulate-phase hexamethyl-p-rosaniline chloride may be removed from the atmosphere by wet and dry deposition. Hexamethyl-p-rosaniline chloride has a UV max of 590 nm indicating a potential for direct photolysis in the environment. If released to soil, hexamethyl-p-rosaniline chloride is expected to have no mobility based upon an estimated Koc of 4X10+6. Hexamethyl-p-rosaniline chloride is a cationic salt and cations generally adsorb to organic carbon and clay more strongly than their neutral counterparts. Volatilization from moist soil surfaces is not expected to be an important fate process based upon an estimated Henry's Law constant of 3.1X10-16 atm-cu m/mole. If released into water, hexamethyl-p-rosaniline chloride isexpected to adsorb to suspended solids and sediment based upon the estimated Koc. Measurable transformation rates of 0.002 to 0.012/hour, that correspond to a half-life range of 2.4 to 14.4 days, were observed in 42 batch culture die-away tests using natural water samples from four sites. The photoreaction of hexamethyl-p-rosaniline chloride in water is reported to give p-dimethylamino phenol, 4,4'-bis dimethylamino benzophenone, the leuco- and demethylated derivative of hexamethyl-p-rosaniline chloride. Volatilization from water surfaces is not expected to be an important fate process based upon this compound's estimated Henry's Law constant. An estimated BCF of 3.2 suggests the potential for bioconcentration in aquatic organisms is low. Occupational exposure to hexamethyl-p-rosaniline chloride may occur through inhalation of dust and dermal contact with this compound at workplaces where hexamethyl-p-rosaniline chloride is produced or used. General population exposure may occur via use of topical medications and consumer products containing this compound. (SRC) [Peer Reviewed] Section XIII. Disposal Considerations Recycle to process, if possible. Consult your local or regional authorities. You may be able to dissolve or mix material with a Waste Disposal combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system. Observe all federal, state, and local regulations when disposing of the substance. Section XIV. Transport Information DOT ClassificationCLASS 9: Miscellaneous hazardous material. UN: 3077 PIN Number Proper Shipping NameEnvironmentally hazardous substance, solid, n.o.s. Packing Group (PG)III DOT Pictograms Continued on Next Page Crystal Violet [Ion association reagent for spectrophotometric analysis.] Section XV. Other Regulatory Information and Pictograms TSCA Chemical InventoryThis compound is ON the EPA Toxic Substances Control Act (TSCA) inventory list. (EPA) WHMIS ClassificationOn DSL. (Canada) EINECS Number (EEC) 208-953-6 EEC Risk StatementsR23/24/25- Toxic by inhalation, in contact with skin and if swallowed. R36/37/38- Irritating to eyes, respiratory system and skin. R45- May cause cancer. SECTION 16 - ADDITIONAL INFORMATION N/A

安全

• 危险品运输编码: 3077
• RTECS号: BO9000000
• 包装等级: III